Free Trial
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free NAII Stock Alerts

Natural Alternatives International (NAII) Financials

Natural Alternatives International logo
$1.18 +0.04 (+3.14%)
As of 02:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Natural Alternatives International

Annual Income Statements for Natural Alternatives International

This table shows Natural Alternatives International's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 9.55 7.24 5.05 6.54 -1.65 11 13 2.52 -7.22 -14 -21
Consolidated Net Income / (Loss)		 9.55 7.24 5.05 6.54 -1.65 11 11 2.52 -7.22 -14 -21
Net Income / (Loss) Continuing Operations		 9.55 7.24 5.05 6.54 -1.65 11 11 2.52 -7.22 -14 -21
Total Pre-Tax Income 		14 10 11 7.95 -1.74 12 14 3.56 -9.46 -11 -20
Total Operating Income		 12 9.70 9.53 5.96 -1.51 14 14 4.71 -8.53 -8.66 -19
Total Gross Profit		 25 26 26 24 19 30 31 18 6.87 9.29 9.00
Total Revenue		 114 122 132 138 119 179 171 154 114 130 143
Operating Revenue		 114 122 132 138 119 179 171 154 114 130 143
Total Cost of Revenue		 89 96 106 115 100 148 140 136 107 121 134
Operating Cost of Revenue		 89 96 106 115 100 148 140 136 107 121 134
Total Operating Expenses		 13 17 17 18 20 17 17 13 15 18 28
Selling, General & Admin Expense		 13 17 17 18 17 17 17 15 15 17 17
Impairment Charge		 - - - - - - - - - 0.00 10
Other Special Charges / (Income)		 - - - - - - - - 0.00 1.40 0.04
Total Other Income / (Expense), net		 1.31 0.41 1.08 1.99 -0.23 -1.55 -0.04 -1.16 -0.93 -2.08 -1.51
Interest Expense		 -0.00 0.00 0.01 0.03 0.07 0.12 0.08 0.45 0.36 0.92 1.19
Interest & Investment Income		 0.13 0.46 1.09 1.87 0.18 0.00 0.00 0.03 0.18 0.17 0.05
Other Income / (Expense), net		 1.18 -0.05 0.00 0.15 -0.34 -1.43 0.04 -0.74 -0.75 -1.33 -0.38
Income Tax Expense		 4.03 2.88 5.56 1.41 -0.09 1.36 2.95 1.03 -2.25 2.84 0.43
Basic Earnings per Share		 $1.46 $1.10 $0.76 $0.96 ($0.25) $1.71 $1.75 $0.43 ($1.23) ($2.28) ($3.43)
Weighted Average Basic Shares Outstanding		 6.52M 6.58M 6.64M 6.81M 6.70M 6.29M 6.12M 5.86M 5.87M 5.95M 6.03M
Diluted Earnings per Share		 $1.44 $1.09 $0.73 $0.92 ($0.25) $1.69 $1.74 $0.43 ($1.23) ($2.28) ($3.43)
Weighted Average Diluted Shares Outstanding		 6.64M 6.66M 6.89M 7.10M 6.70M 6.38M 6.16M 5.88M 5.87M 5.95M 6.03M
Weighted Average Basic & Diluted Shares Outstanding		 6.87M 7.44M 7.56M 7.23M 6.52M 6.43M 6.09M 6.09M 6.20M 6.18M 22.11M

Quarterly Income Statements for Natural Alternatives International

This table shows Natural Alternatives International's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -3.07 -1.46 -1.99 -1.98 -2.19 -2.19 -7.22 -0.29 -2.55 -4.31 -14
Consolidated Net Income / (Loss)		 -3.07 -1.58 -1.87 -1.98 -2.19 -2.19 -7.22 -0.29 -2.55 -4.31 -14
Net Income / (Loss) Continuing Operations		 -3.07 -1.58 -1.87 -1.98 -2.19 -2.19 -7.22 -0.29 -2.55 -4.31 -14
Total Pre-Tax Income 		-3.83 -1.97 -2.78 -2.41 -2.87 -2.64 -2.82 -0.20 -2.33 -4.24 -13
Total Operating Income		 -3.51 -1.95 -2.53 -1.84 -2.78 -2.10 -1.94 0.28 -1.85 -4.01 -13
Total Gross Profit		 0.39 1.92 1.42 2.26 1.67 1.83 3.54 4.40 2.49 0.38 1.73
Total Revenue		 25 25 29 33 34 29 34 38 35 35 35
Operating Revenue		 25 25 29 33 34 29 34 38 35 35 35
Total Cost of Revenue		 25 23 28 31 32 27 30 33 32 35 33
Operating Cost of Revenue		 25 23 28 31 32 27 30 33 32 35 33
Total Operating Expenses		 3.90 3.87 3.94 4.10 4.45 3.93 5.48 4.11 4.34 4.40 15
Selling, General & Admin Expense		 3.90 3.87 3.94 4.10 4.45 3.93 4.08 4.11 4.34 4.40 4.45
Total Other Income / (Expense), net		 -0.32 -0.03 -0.24 -0.58 -0.09 -0.54 -0.88 -0.48 -0.48 -0.23 -0.32
Interest Expense		 0.07 0.07 0.12 0.18 0.28 0.25 0.21 0.23 0.22 0.27 0.47
Interest & Investment Income		 0.01 0.08 0.08 0.03 0.04 0.05 0.04 0.03 0.00 0.00 0.02
Other Income / (Expense), net		 -0.26 -0.04 -0.19 -0.43 0.15 -0.35 -0.71 -0.29 -0.26 0.04 0.13
Income Tax Expense		 -0.76 -0.39 -0.91 -0.43 -0.68 -0.46 4.40 0.09 0.22 0.07 0.05
Basic Earnings per Share		 ($0.52) ($0.27) ($0.32) ($0.33) ($0.37) ($0.37) ($1.21) ($0.05) ($0.42) ($0.72) ($2.24)
Weighted Average Basic Shares Outstanding		 5.85M 5.87M 5.87M 5.92M 5.92M 5.94M 5.95M 6.01M 6.01M 6.03M 6.03M
Diluted Earnings per Share		 ($0.52) ($0.27) ($0.32) ($0.33) ($0.37) ($0.37) ($1.21) ($0.05) ($0.42) ($0.72) ($2.24)
Weighted Average Diluted Shares Outstanding		 5.85M 5.87M 5.87M 5.92M 5.92M 5.94M 5.95M 6.01M 6.01M 6.03M 6.03M
Weighted Average Basic & Diluted Shares Outstanding		 6.09M 3.28M 6.20M 6.20M 6.20M 6.18M 6.18M 6.18M 6.18M 6.28M 22.11M

Annual Cash Flow Statements for Natural Alternatives International

This table details how cash moves in and out of Natural Alternatives International's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Change in Cash & Equivalents		 1.20 8.10 -4.23 1.43 5.44 1.66 -10 -8.23 -1.62 0.34 -4.85
Net Cash From Operating Activities		 9.29 14 1.83 6.56 3.69 21 12 7.02 -1.50 5.93 -8.92
Net Cash From Continuing Operating Activities		 9.29 14 1.83 6.56 3.69 21 12 7.02 -1.50 5.93 -8.92
Net Income / (Loss) Continuing Operations		 9.55 7.24 5.05 6.54 -1.65 11 11 2.52 -7.22 -14 -21
Consolidated Net Income / (Loss)		 9.55 7.24 5.05 6.54 -1.65 11 11 2.52 -7.22 -14 -21
Depreciation Expense		 1.77 2.38 2.91 3.47 3.96 4.34 4.17 4.25 4.65 4.56 4.71
Non-Cash Adjustments To Reconcile Net Income		 -1.03 1.25 1.86 1.86 5.44 1.59 0.66 0.32 4.33 5.53 11
Changes in Operating Assets and Liabilities, net		 -1.01 3.27 -7.99 -5.30 -4.06 4.11 -3.68 -0.07 -3.25 9.42 -4.09
Net Cash From Investing Activities		 -7.44 -5.33 -5.55 -3.81 -4.51 -5.04 -26 -13 -3.02 -3.61 -3.70
Net Cash From Continuing Investing Activities		 -7.44 -5.33 -5.55 -3.81 -4.51 -5.04 -26 -13 -3.02 -3.61 -3.70
Purchase of Property, Plant & Equipment		 -10 -5.35 -4.08 -5.33 -4.54 -5.11 -26 -14 -3.02 -3.61 -3.70
Net Cash From Financing Activities		 -0.65 -0.71 -0.51 -1.33 6.25 -14 4.29 -1.78 2.89 -1.97 7.77
Net Cash From Continuing Financing Activities		 -0.65 -0.71 -0.51 -1.33 6.25 -14 4.29 -1.78 2.89 -1.97 7.77
Repayment of Debt		 - - - - - 0.00 -0.21 -0.28 -0.29 -33 -70
Repurchase of Common Equity		 -0.65 -0.71 -0.51 -1.37 -3.75 -4.15 -5.50 -1.50 -0.22 -0.18 -0.09
Issuance of Debt		 - - - 0.00 10 -10 10 0.00 3.40 31 78
Cash Interest Paid		 0.00 0.00 0.01 0.02 0.07 0.13 0.21 0.80 0.29 0.81 1.08
Cash Income Taxes Paid		 3.36 2.89 1.82 1.97 0.99 2.96 2.61 1.84 0.46 0.32 0.44

Quarterly Cash Flow Statements for Natural Alternatives International

This table details how cash moves in and out of Natural Alternatives International's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -0.15 -4.19 -0.43 -1.83 -1.49 1.95 1.71 -4.58 -3.99 5.44 -1.72
Net Cash From Operating Activities		 0.35 -3.62 -2.72 -3.44 0.04 5.99 3.35 -4.02 -6.33 2.50 -1.07
Net Cash From Continuing Operating Activities		 0.35 -3.62 -2.72 -3.44 0.04 5.99 3.35 -4.02 -6.33 2.50 -1.07
Net Income / (Loss) Continuing Operations		 -3.07 -1.58 -1.87 -1.98 -2.19 -2.19 -7.22 -0.29 -2.55 -4.31 -14
Consolidated Net Income / (Loss)		 -3.07 -1.58 -1.87 -1.98 -2.19 -2.19 -7.22 -0.29 -2.55 -4.31 -14
Depreciation Expense		 1.19 1.10 1.21 1.13 1.13 1.14 1.16 1.17 1.17 1.19 1.18
Non-Cash Adjustments To Reconcile Net Income		 3.72 -1.87 1.97 2.11 -0.21 0.57 3.05 0.25 0.34 3.87 6.71
Changes in Operating Assets and Liabilities, net		 -1.50 -1.28 -4.02 -4.70 1.30 6.47 6.35 -5.15 -5.28 1.75 4.58
Net Cash From Investing Activities		 -0.43 -0.28 -1.03 -0.30 -1.06 -0.80 -1.46 -1.03 -0.93 -1.10 -0.64
Net Cash From Continuing Investing Activities		 -0.43 -0.28 -1.03 -0.30 -1.06 -0.80 -1.46 -1.03 -0.93 -1.10 -0.64
Purchase of Property, Plant & Equipment		 -0.43 -0.28 -1.03 -0.30 -1.06 -0.80 -1.46 -1.03 -0.93 -1.10 -0.64
Net Cash From Financing Activities		 -0.07 -0.29 3.33 1.92 -0.47 -3.24 -0.18 0.47 3.27 4.04 -0.02
Net Cash From Continuing Financing Activities		 -0.07 -0.29 3.33 1.92 -0.47 -3.24 -0.18 0.47 3.27 4.04 -0.02
Repayment of Debt		 -0.07 -0.07 -0.07 -0.07 -0.07 -0.08 -0.07 -0.07 -0.08 -0.08 -70
Repurchase of Common Equity		 - -0.22 -0.00 -0.01 - -0.17 -0.00 -0.01 - -0.08 -0.00
Issuance of Debt		 - - 3.40 2.00 -0.40 -3.00 -0.10 0.55 3.35 4.20 70
Cash Interest Paid		 0.06 0.07 0.10 0.16 0.26 0.22 0.19 0.15 0.21 0.27 0.45
Cash Income Taxes Paid		 0.02 0.01 0.18 0.00 0.35 0.01 -0.04 0.41 0.00 0.00 0.02

Annual Balance Sheets for Natural Alternatives International

This table presents Natural Alternatives International's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Assets		 74 73 85 93 120 120 146 134 162 152 126
Total Current Assets		 56 52 65 71 79 80 77 57 62 59 65
Cash & Equivalents		 20 28 24 25 30 32 22 14 12 12 7.39
Restricted Cash		 - - - - - - - - - 0.00 0.09
Accounts Receivable		 13 8.41 15 16 17 18 17 7.02 17 15 21
Inventories, net		 21 14 24 26 28 27 32 30 24 25 31
Prepaid Expenses		 2.14 1.46 1.83 1.50 2.28 2.17 1.81 6.00 8.00 7.07 2.58
Other Current Assets		 - - 0.06 1.98 0.45 0.00 3.14 0.39 0.49 0.37 3.98
Plant, Property, & Equipment, net		 15 18 19 21 22 22 45 54 52 51 36
Total Noncurrent Assets		 3.13 2.78 0.73 1.02 20 18 25 23 49 42 25
Other Noncurrent Operating Assets		 0.90 0.77 0.73 1.02 19 17 25 23 45 42 25
Total Liabilities & Shareholders' Equity		 74 73 85 93 120 120 146 134 162 152 126
Total Liabilities		 20 11 17 17 49 40 57 45 80 84 76
Total Current Liabilities		 19 10 14 14 28 22 24 16 23 29 38
Short-Term Debt		 - - - 0.00 10 0.00 0.30 0.31 3.70 2.21 8.48
Accounts Payable		 13 5.12 9.65 8.63 13 12 16 7.78 13 15 18
Accrued Expenses		 2.24 2.35 2.35 2.78 1.57 2.44 2.79 2.41 2.85 3.52 4.60
Customer Deposits		 - - - - - 1.72 0.14 0.32 0.30 1.36 1.32
Current Employee Benefit Liabilities		 2.80 1.59 1.50 1.62 2.66 4.58 3.67 2.25 2.09 2.17 2.45
Other Current Liabilities		 - - - - 0.00 0.81 0.63 2.45 1.29 4.19 2.72
Total Noncurrent Liabilities		 1.24 1.19 2.68 3.16 21 18 34 29 56 55 39
Long-Term Debt		 - - - - - 0.00 9.49 9.21 8.93 8.63 10
Noncurrent Employee Benefit Liabilities		 0.76 0.56 0.05 0.25 0.70 0.39 0.34 0.34 0.14 0.11 0.00
Other Noncurrent Operating Liabilities		 0.00 0.10 - 0.00 19 16 21 19 46 46 29
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 54 61 68 76 71 80 89 89 83 68 50
Total Preferred & Common Equity		 54 61 68 76 71 80 89 89 83 68 50
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 54 61 68 76 71 80 89 89 83 68 50
Common Stock		 21 22 25 26 28 30 31 32 33 34 34
Retained Earnings		 39 46 51 57 56 67 78 80 73 59 39
Treasury Stock		 -5.36 -6.07 -6.58 -7.96 -12 -16 -21 -23 -23 -23 -23
Accumulated Other Comprehensive Income / (Loss)		 -0.68 -0.91 -0.58 0.29 -1.18 -0.56 1.70 -0.08 -0.02 -1.42 0.30

Quarterly Balance Sheets for Natural Alternatives International

This table presents Natural Alternatives International's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 160 156 153 161 156 155 157 153 155
Total Current Assets		 58 54 54 62 59 59 65 62 64
Cash & Equivalents		 17 17 12 10 8.66 11 7.74 3.75 9.20
Accounts Receivable		 9.75 10 11 18 17 12 19 18 21
Inventories, net		 23 20 21 26 23 27 31 33 30
Prepaid Expenses		 6.83 6.45 7.67 8.74 7.99 7.71 7.56 6.29 4.14
Current Deferred & Refundable Income Taxes		 0.34 0.88 1.66 - 0.92 1.36 0.18 0.12 0.07
Other Current Assets		 0.79 0.41 0.34 0.03 1.04 0.20 0.00 0.16 0.07
Plant, Property, & Equipment, net		 54 53 52 51 51 51 51 51 51
Total Noncurrent Assets		 49 48 46 48 47 46 41 41 40
Other Noncurrent Operating Assets		 48 48 46 44 44 43 41 41 40
Total Liabilities & Shareholders' Equity		 160 156 153 161 156 155 157 153 155
Total Liabilities		 71 70 69 81 77 78 88 86 92
Total Current Liabilities		 15 13 14 24 22 23 34 33 39
Short-Term Debt		 0.29 0.29 0.29 5.70 5.30 2.30 2.76 6.11 10
Accounts Payable		 7.61 7.49 6.97 9.95 8.60 13 20 17 18
Accrued Expenses		 2.72 2.01 2.43 2.71 2.25 2.19 3.76 3.67 3.37
Customer Deposits		 0.41 0.70 0.39 0.64 1.17 1.52 0.93 - 1.32
Current Deferred & Payable Income Tax Liabilities		 0.20 0.00 0.00 0.09 0.00 0.00 0.00 0.00 0.00
Current Employee Benefit Liabilities		 2.37 1.66 2.09 2.86 2.13 2.41 3.03 2.51 3.25
Other Current Liabilities		 1.85 1.26 1.48 2.51 2.21 2.07 3.33 2.81 2.72
Total Noncurrent Liabilities		 56 57 55 57 55 55 54 53 53
Long-Term Debt		 9.15 9.08 9.01 8.86 8.78 8.70 8.55 8.47 8.39
Noncurrent Employee Benefit Liabilities		 0.33 0.35 0.30 0.14 0.16 0.16 0.12 0.14 0.15
Other Noncurrent Operating Liabilities		 46 47 45 47 46 45 45 45 44
Commitments & Contingencies		 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 89 85 84 80 79 77 69 67 63
Total Preferred & Common Equity		 89 85 84 80 79 77 69 67 63
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 89 85 84 80 79 77 69 67 63
Common Stock		 32 32 32 33 33 34 34 34 34
Retained Earnings		 79 76 75 71 69 67 59 57 52
Treasury Stock		 -23 -23 -23 -23 -23 -23 -23 -23 -23
Accumulated Other Comprehensive Income / (Loss)		 0.35 -0.24 -0.12 -0.72 0.15 -0.26 -0.70 -0.30 0.02

Annual Metrics And Ratios for Natural Alternatives International

This table displays calculated financial ratios and metrics derived from Natural Alternatives International's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
DEI Shares Outstanding		 6,868,627.00 6,938,352.00 7,558,409.00 7,258,647.00 6,788,366.00 6,418,978.00 6,150,452.00 6,077,213.00 3,280,037.00 6,178,898.00 6,275,229.00
DEI Adjusted Shares Outstanding		 6,868,627.00 6,938,352.00 7,558,409.00 7,258,647.00 6,788,366.00 6,418,978.00 6,150,452.00 6,077,213.00 3,280,037.00 6,178,898.00 6,275,229.00
DEI Earnings Per Adjusted Shares Outstanding		 1.39 1.04 0.67 0.90 -0.24 1.68 2.11 0.42 -2.20 -2.20 -3.30
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 43.63% 6.78% 8.60% 4.42% -14.04% 50.17% -4.23% -9.91% -26.11% 14.12% 9.75%
EBITDA Growth		 126.56% -20.85% 3.37% -23.03% -77.96% 685.41% 7.88% -54.03% -156.33% -17.29% -165.42%
EBIT Growth		 213.78% -28.16% -1.22% -35.89% -130.23% 762.45% 12.09% -71.05% -333.55% -7.69% -91.42%
NOPAT Growth		 166.84% -19.48% -34.65% 8.06% -121.55% 1,249.47% -11.65% -68.83% -278.67% -1.48% -116.54%
Net Income Growth		 185.30% -24.21% -30.19% 29.50% -125.15% 754.59% -0.52% -76.46% -386.16% -88.10% -52.45%
EPS Growth		 193.88% -24.31% -33.03% 26.03% -127.17% 776.00% 2.96% -75.29% -386.05% -85.37% -50.44%
Operating Cash Flow Growth		 246.71% 52.26% -87.03% 258.10% -43.77% 463.70% -42.97% -40.85% -121.33% 496.26% -250.30%
Free Cash Flow Firm Growth		 -105.69% 15,896.65% -189.19% 77.83% 35.52% 1,659.85% -217.51% 72.71% 6.74% 326.11% -171.88%
Invested Capital Growth		 34.26% -1.98% 34.02% 14.36% -0.17% -5.90% 59.50% 10.73% -1.70% -19.59% -8.61%
Revenue Q/Q Growth		 12.98% -2.80% 5.60% -6.08% 4.24% 5.49% -0.71% -4.51% -5.33% 3.49% 0.45%
EBITDA Q/Q Growth		 26.23% -16.45% 12.86% -28.79% 416.97% 10.44% 21.83% -29.90% -557.71% 0.35% -256.58%
EBIT Q/Q Growth		 33.15% -21.44% 17.28% -40.28% 59.62% 14.20% 32.77% -49.28% -155.83% 0.67% -119.12%
NOPAT Q/Q Growth		 41.66% -21.81% 26.81% -36.53% 65.59% 9.01% 21.54% -44.30% -201.02% 6.29% -149.33%
Net Income Q/Q Growth		 34.56% -20.87% 36.48% -31.99% 54.76% 12.12% 28.56% -56.72% -118.30% -64.89% -44.01%
EPS Q/Q Growth		 35.85% -20.44% 32.73% -32.85% 55.36% 12.67% 27.01% -53.26% -119.64% -64.03% -42.92%
Operating Cash Flow Q/Q Growth		 230.66% -4.42% -83.28% 38.95% -11.02% 43.23% 49.65% -15.17% -117.19% 4,663.08% -97.91%
Free Cash Flow Firm Q/Q Growth		 97.21% 58.35% -219.64% 76.55% 14.39% 42.43% 9.18% -105.90% 94.54% 511.41% -748.84%
Invested Capital Q/Q Growth		 2.19% -10.76% 26.73% 3.39% 7.43% 0.03% 0.15% 0.00% 2.78% -13.09% -15.76%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 22.12% 21.49% 19.87% 17.05% 15.87% 17.05% 17.85% 11.79% 6.03% 7.15% 6.31%
EBITDA Margin		 13.32% 9.87% 9.40% 6.93% 1.78% 9.29% 10.46% 5.34% -4.07% -4.18% -10.12%
Operating Margin		 10.73% 7.96% 7.20% 4.31% -1.27% 7.66% 8.00% 3.06% -7.50% -6.67% -13.16%
EBIT Margin		 11.77% 7.92% 7.20% 4.42% -1.55% 6.86% 8.03% 2.58% -8.15% -7.70% -13.42%
Profit (Net Income) Margin		 8.36% 5.93% 3.81% 4.73% -1.38% 6.03% 6.27% 1.64% -6.34% -10.45% -14.52%
Tax Burden Percent		 70.34% 71.56% 47.59% 82.25% 94.65% 88.81% 78.42% 70.94% 76.26% 126.40% 102.12%
Interest Burden Percent		 100.99% 104.72% 111.28% 130.08% 94.05% 99.04% 99.54% 89.48% 101.99% 107.48% 105.94%
Effective Tax Rate		 29.66% 28.44% 52.41% 17.75% 0.00% 11.19% 21.58% 29.06% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 29.08% 20.64% 11.64% 10.25% -2.07% 24.55% 17.24% 4.15% -7.11% -8.07% -20.49%
ROIC Less NNEP Spread (ROIC-NNEP)		 24.26% 19.41% 9.64% 3.51% 0.52% 29.78% 17.31% 14.34% 65.19% 1,772.26% -176.19%
Return on Net Nonoperating Assets (RNNOA)		 -9.52% -8.04% -3.84% -1.18% -0.16% -10.33% -4.54% -1.30% -1.31% -9.90% -14.47%
Return on Equity (ROE)		 19.56% 12.60% 7.81% 9.06% -2.23% 14.22% 12.71% 2.85% -8.42% -17.98% -34.96%
Cash Return on Invested Capital (CROIC)		 -0.16% 22.64% -17.43% -3.15% -1.90% 30.64% -28.62% -6.03% -5.40% 13.65% -11.50%
Operating Return on Assets (OROA)		 21.00% 13.16% 12.09% 6.84% -1.73% 10.18% 10.31% 2.84% -6.26% -6.36% -13.74%
Return on Assets (ROA)		 14.92% 9.86% 6.40% 7.32% -1.54% 8.96% 8.05% 1.80% -4.87% -8.64% -14.87%
Return on Common Equity (ROCE)		 19.56% 12.60% 7.81% 9.06% -2.23% 14.22% 12.71% 2.85% -8.42% -17.98% -34.96%
Return on Equity Simple (ROE_SIMPLE)		 17.77% 11.83% 7.40% 8.60% -2.30% 13.45% 12.10% 2.84% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 8.62 6.94 4.54 4.90 -1.06 12 11 3.34 -5.97 -6.06 -13
NOPAT Margin		 7.55% 5.69% 3.43% 3.55% -0.89% 6.80% 6.27% 2.17% -5.25% -4.67% -9.21%
Net Nonoperating Expense Percent (NNEP)		 4.83% 1.23% 2.00% 6.73% -2.59% -5.23% -0.07% -10.19% -72.30% -1,780.33% 155.70%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -6.27% -7.65% -19.12%
Cost of Revenue to Revenue		 77.88% 78.51% 80.13% 82.95% 84.13% 82.95% 82.08% 88.21% 93.97% 92.85% 93.69%
SG&A Expenses to Revenue		 11.38% 13.53% 12.68% 12.74% 14.38% 9.47% 9.91% 9.65% 13.53% 12.74% 12.14%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 11.38% 13.53% 12.68% 12.74% 17.14% 9.39% 9.91% 8.73% 13.53% 13.82% 19.47%
Earnings before Interest and Taxes (EBIT)		 13 9.66 9.54 6.11 -1.85 12 14 3.97 -9.28 -9.99 -19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 15 12 12 9.58 2.11 17 18 8.22 -4.63 -5.43 -14
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.41 1.13 1.12 1.11 0.65 1.35 0.73 0.49 0.24 0.30 0.30
Price to Tangible Book Value (P/TBV)		 1.41 1.13 1.12 1.11 0.65 1.35 0.73 0.49 0.24 0.30 0.30
Price to Revenue (P/Rev)		 0.66 0.57 0.58 0.61 0.39 0.61 0.38 0.28 0.17 0.16 0.11
Price to Earnings (P/E)		 7.94 9.54 15.19 12.94 0.00 10.03 4.95 17.35 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 12.59% 10.48% 6.58% 7.73% 0.00% 9.97% 20.20% 5.76% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.65 1.24 1.19 1.17 0.51 1.58 0.68 0.47 0.25 0.28 0.43
Enterprise Value to Revenue (EV/Rev)		 0.49 0.34 0.40 0.43 0.22 0.43 0.31 0.26 0.18 0.14 0.18
Enterprise Value to EBITDA (EV/EBITDA)		 3.69 3.42 4.27 6.22 12.29 4.58 2.92 4.82 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 4.17 4.27 5.57 9.75 0.00 6.20 3.80 9.98 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 6.50 5.93 11.70 12.16 0.00 6.25 4.86 11.86 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 6.04 2.91 28.97 9.08 7.03 3.65 4.40 5.65 0.00 3.17 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 5.41 0.00 0.00 0.00 5.01 0.00 0.00 0.00 1.83 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.14 0.00 0.11 0.11 0.15 0.16 0.37
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.10 0.11 0.13 0.20
Financial Leverage		 -0.39 -0.41 -0.40 -0.34 -0.31 -0.35 -0.26 -0.09 -0.02 -0.01 0.08
Leverage Ratio		 1.31 1.28 1.22 1.24 1.45 1.59 1.58 1.58 1.73 2.08 2.35
Compound Leverage Factor		 1.32 1.34 1.36 1.61 1.36 1.57 1.57 1.41 1.76 2.24 2.49
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 12.29% 0.00% 9.96% 9.68% 13.26% 13.67% 27.22%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 12.29% 0.00% 0.31% 0.32% 3.88% 2.78% 12.36%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 9.66% 9.37% 9.38% 10.89% 14.87%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 87.71% 100.00% 90.04% 90.32% 86.74% 86.33% 72.78%
Debt to EBITDA		 0.00 0.00 0.00 0.00 4.74 0.00 0.55 1.16 -2.73 -1.99 -1.30
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 -9.70 0.00 -0.67 -0.50 -0.14 0.27 -0.78
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.53 1.12 -1.93 -1.59 -0.71
Debt to NOPAT		 0.00 0.00 0.00 0.00 -9.47 0.00 0.91 2.85 -2.11 -1.79 -1.42
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 19.39 0.00 -1.12 -1.22 -0.11 0.25 -0.85
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.88 2.75 -1.50 -1.42 -0.78
Altman Z-Score		 5.68 7.30 6.19 6.21 2.67 4.79 3.33 3.03 1.57 1.57 1.44
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.91 5.03 4.56 5.01 2.84 3.64 3.21 3.59 2.63 2.06 1.73
Quick Ratio		 1.72 3.53 2.78 2.88 1.71 2.27 1.64 1.30 1.23 0.94 0.74
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -0.05 7.62 -6.79 -1.51 -0.97 15 -18 -4.86 -4.53 10 -7.37
Operating Cash Flow to CapEx		 124.78% 265.28% 45.23% 123.66% 81.91% 412.90% 44.85% 52.12% -49.62% 164.14% -240.91%
Free Cash Flow to Firm to Interest Expense		 0.00 2,538.78 -754.78 -51.94 -14.50 128.40 -214.51 -10.77 -12.55 11.20 -6.21
Operating Cash Flow to Interest Expense		 0.00 4,712.33 203.67 226.34 55.09 176.32 142.96 15.56 -4.15 6.48 -7.52
Operating Cash Flow Less CapEx to Interest Expense		 0.00 2,936.00 -246.67 43.31 -12.16 133.62 -175.81 -14.30 -12.50 2.53 -10.64
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.78 1.66 1.68 1.55 1.11 1.48 1.28 1.10 0.77 0.83 1.02
Accounts Receivable Turnover		 9.88 11.28 11.50 9.04 7.21 10.22 9.67 12.60 9.52 8.24 8.08
Inventory Turnover		 5.34 5.55 5.69 4.63 3.71 5.39 4.72 4.37 3.96 4.91 4.80
Fixed Asset Turnover		 10.02 7.32 7.08 6.85 5.58 8.15 5.12 3.13 2.15 2.52 3.30
Accounts Payable Turnover		 10.18 10.68 14.37 12.55 9.46 12.14 10.00 11.34 10.42 8.58 7.97
Days Sales Outstanding (DSO)		 36.93 32.37 31.74 40.36 50.61 35.73 37.75 28.96 38.35 44.32 45.20
Days Inventory Outstanding (DIO)		 68.39 65.76 64.14 78.86 98.50 67.76 77.35 83.51 92.07 74.35 76.03
Days Payable Outstanding (DPO)		 35.84 34.19 25.39 29.09 38.58 30.07 36.51 32.19 35.02 42.52 45.79
Cash Conversion Cycle (CCC)		 69.49 63.93 70.49 90.14 110.52 73.41 78.59 80.29 95.40 76.15 75.44
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 34 33 45 51 51 48 76 85 83 67 61
Invested Capital Turnover		 3.85 3.62 3.40 2.89 2.33 3.61 2.75 1.91 1.36 1.73 2.22
Increase / (Decrease) in Invested Capital		 8.67 -0.67 11 6.41 -0.09 -3.01 29 8.20 -1.44 -16 -5.76
Enterprise Value (EV)		 56 41 53 60 26 76 52 40 20 19 26
Market Capitalization		 76 69 77 85 46 108 64 44 20 20 15
Book Value per Share		 $7.82 $8.81 $9.03 $10.48 $10.51 $12.48 $14.39 $14.61 $25.18 $11.07 $7.96
Tangible Book Value per Share		 $7.82 $8.81 $9.03 $10.48 $10.51 $12.48 $14.39 $14.61 $25.18 $11.07 $7.96
Total Capital		 54 61 68 76 81 80 98 98 95 79 69
Total Debt		 0.00 0.00 0.00 0.00 10 0.00 9.80 9.52 13 11 19
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 9.49 9.21 8.93 8.63 10
Net Debt		 -20 -28 -24 -25 -20 -32 -12 -4.09 0.65 -1.49 11
Capital Expenditures (CapEx)		 7.44 5.33 4.05 5.31 4.51 5.04 26 13 3.02 3.61 3.70
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 17 14 27 32 31 26 31 28 30 20 29
Debt-free Net Working Capital (DFNWC)		 37 41 51 57 61 58 53 41 42 33 36
Net Working Capital (NWC)		 37 41 51 57 51 58 53 41 38 30 28
Net Nonoperating Expense (NNE)		 -0.92 -0.29 -0.51 -1.64 0.59 1.37 0.02 0.82 1.24 7.51 7.57
Net Nonoperating Obligations (NNO)		 -20 -28 -24 -25 -20 -32 -12 -4.09 0.65 -1.49 11
Total Depreciation and Amortization (D&A)		 1.77 2.38 2.91 3.47 3.96 4.34 4.17 4.25 4.65 4.56 4.71
Debt-free, Cash-free Net Working Capital to Revenue		 14.82% 11.14% 20.61% 23.21% 25.86% 14.64% 18.32% 18.07% 26.24% 15.67% 20.16%
Debt-free Net Working Capital to Revenue		 32.12% 33.97% 38.44% 41.32% 51.50% 32.64% 31.09% 26.91% 36.77% 25.16% 25.40%
Net Working Capital to Revenue		 32.12% 33.97% 38.44% 41.32% 43.09% 32.64% 30.91% 26.70% 33.52% 23.47% 19.45%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.46 $1.10 $0.76 $0.96 ($0.25) $1.71 $1.75 $0.43 ($1.23) ($2.28) ($3.43)
Adjusted Weighted Average Basic Shares Outstanding		 6.52M 6.58M 6.64M 6.81M 6.70M 6.29M 6.12M 5.86M 5.87M 5.95M 6.03M
Adjusted Diluted Earnings per Share		 $1.44 $1.09 $0.73 $0.92 ($0.25) $1.69 $1.74 $0.43 ($1.23) ($2.28) ($3.43)
Adjusted Weighted Average Diluted Shares Outstanding		 6.64M 6.66M 6.89M 7.10M 6.70M 6.38M 6.16M 5.88M 5.87M 5.95M 6.03M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 6.87M 7.44M 7.56M 7.23M 6.52M 6.43M 6.09M 6.09M 6.20M 6.18M 22.11M
Normalized Net Operating Profit after Tax (NOPAT)		 8.62 6.94 6.67 4.90 -1.06 12 11 3.34 -5.97 -5.08 -5.81
Normalized NOPAT Margin		 7.55% 5.69% 5.04% 3.55% -0.89% 6.80% 6.27% 2.17% -5.25% -3.91% -4.08%
Pre Tax Income Margin		 11.88% 8.29% 8.01% 5.75% -1.46% 6.79% 7.99% 2.31% -8.32% -8.27% -14.22%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 3,218.33 1,059.67 210.83 -27.58 103.75 165.33 8.81 -25.70 -10.92 -16.13
NOPAT to Interest Expense		 0.00 2,314.11 504.11 169.06 -15.77 102.90 129.25 7.41 -16.55 -6.63 -11.07
EBIT Less CapEx to Interest Expense		 0.00 1,442.00 609.33 27.79 -94.84 61.04 -153.45 -21.05 -34.06 -14.87 -19.25
NOPAT Less CapEx to Interest Expense		 0.00 537.78 53.78 -13.98 -83.02 60.19 -189.52 -22.45 -24.91 -10.57 -14.19
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 6.79% 9.84% 10.10% 20.90% -227.78% 38.51% 51.37% 59.60% -3.06% -1.31% -0.43%

Quarterly Metrics And Ratios for Natural Alternatives International

This table displays calculated financial ratios and metrics derived from Natural Alternatives International's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 6,088,813.00 6,088,813.00 3,280,037.00 6,198,778.00 12,397,556.00 6,198,778.00 6,178,898.00 6,176,778.00 - 6,176,778.00 6,275,229.00
DEI Adjusted Shares Outstanding		 6,088,813.00 6,088,813.00 3,280,037.00 6,198,778.00 12,397,556.00 6,198,778.00 6,178,898.00 6,176,778.00 - 6,176,778.00 6,275,229.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.50 -0.24 -0.61 -0.32 -0.18 -0.35 -1.17 -0.05 - -0.70 -2.16
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -40.41% -23.13% -17.84% -2.41% 35.22% 14.44% 14.84% 13.82% 2.10% 23.35% 1.90%
EBITDA Growth		 -175.58% 46.74% -136.46% -427.87% 42.08% -46.80% 1.26% 201.93% 37.19% -112.46% -696.84%
EBIT Growth		 -261.84% 25.89% -192.51% -183.50% 30.34% -23.03% 2.47% 99.87% 19.93% -62.36% -392.56%
NOPAT Growth		 -224.78% 21.54% -174.88% -237.50% 20.87% -7.58% 23.01% 115.47% 33.56% -91.14% -577.73%
Net Income Growth		 -269.33% 33.73% -192.00% -185.18% 28.63% -38.53% -285.06% 85.32% -16.52% -97.21% -87.64%
EPS Growth		 -267.74% 34.15% -191.43% -175.00% 28.85% -37.04% -278.13% 84.85% -13.51% -94.59% -85.12%
Operating Cash Flow Growth		 -95.80% 13.82% -136.28% -176.58% -89.37% 265.37% 223.11% -16.85% -17,208.11% -58.23% -131.87%
Free Cash Flow Firm Growth		 -191.29% -210.37% 94.43% 94.68% 89.74% 103.05% 4,692.38% 379.73% 165.15% -36.71% -123.16%
Invested Capital Growth		 0.00% 0.00% -1.70% 3.77% 8.09% -4.91% -19.59% -14.18% -7.90% -5.71% -8.61%
Revenue Q/Q Growth		 -25.81% -0.26% 17.32% 12.41% 2.80% -15.59% 17.73% 11.41% -7.78% 1.97% -2.75%
EBITDA Q/Q Growth		 -841.67% 65.48% -69.25% 24.34% -31.03% 12.51% -13.84% 178.11% -180.74% -195.95% -326.95%
EBIT Q/Q Growth		 -371.75% 47.30% -36.55% 16.49% -15.92% 6.92% -8.26% 99.89% -70,066.67% -88.74% -228.42%
NOPAT Q/Q Growth		 -545.77% 44.44% -29.35% 27.29% -51.42% 24.46% 7.43% 114.61% -750.35% -117.33% -228.23%
Net Income Q/Q Growth		 -341.73% 48.60% -18.76% -5.76% -10.54% 0.23% -230.10% 95.97% -777.32% -68.86% -214.08%
EPS Q/Q Growth		 -333.33% 48.08% -18.52% -3.13% -12.12% 0.00% -227.03% 95.87% -740.00% -71.43% -211.11%
Operating Cash Flow Q/Q Growth		 -92.26% -1,141.38% 25.03% -26.72% 101.07% 16,097.30% -44.18% -220.27% -57.35% 139.54% -142.59%
Free Cash Flow Firm Q/Q Growth		 1.47% -2.07% 99.60% -1,239.54% -89.78% 130.31% 496.02% -18.41% -55.80% -70.56% -318.09%
Invested Capital Q/Q Growth		 -4.02% 3.53% 2.78% 1.61% -0.03% -8.92% -13.09% 8.45% 7.29% -6.75% -15.76%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 1.54% 7.65% 4.81% 6.81% 4.90% 6.35% 10.44% 11.65% 7.16% 1.08% 5.00%
EBITDA Margin		 -10.24% -3.54% -5.11% -3.44% -4.39% -4.55% -4.40% 3.08% -2.70% -7.83% -34.38%
Operating Margin		 -13.94% -7.77% -8.56% -5.54% -8.16% -7.30% -5.74% 0.75% -5.31% -11.31% -38.18%
EBIT Margin		 -14.98% -7.91% -9.21% -6.84% -7.71% -8.51% -7.82% -0.01% -6.05% -11.20% -37.81%
Profit (Net Income) Margin		 -12.18% -6.28% -6.35% -5.98% -6.43% -7.60% -21.31% -0.77% -7.34% -12.15% -39.24%
Tax Burden Percent		 80.14% 80.18% 67.39% 82.14% 76.45% 82.74% 255.98% 146.23% 109.62% 101.60% 100.34%
Interest Burden Percent		 101.51% 98.94% 102.39% 106.39% 109.01% 107.97% 106.42% 6,633.33% 110.64% 106.80% 103.42%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -31.87% -16.14% -8.12% -5.27% -8.55% -8.12% -6.95% 0.90% -6.18% -15.02% -59.46%
ROIC Less NNEP Spread (ROIC-NNEP)		 -14.96% -2.51% -1.93% 42.70% 18.60% 44.72% 1,380.54% -11.40% -21.69% -45.33% -148.28%
Return on Net Nonoperating Assets (RNNOA)		 1.26% 0.09% 0.04% -0.73% -0.20% -0.75% -7.72% -0.61% -2.41% -3.21% -12.18%
Return on Equity (ROE)		 -30.61% -16.04% -8.08% -6.01% -8.75% -8.87% -14.66% 0.29% -8.59% -18.23% -71.64%
Cash Return on Invested Capital (CROIC)		 -206.03% -204.90% -5.40% -11.98% -15.60% -3.15% 13.65% 9.44% 3.40% -1.16% -11.50%
Operating Return on Assets (OROA)		 -12.29% -6.21% -7.07% -4.81% -6.03% -6.93% -6.46% -0.01% -5.29% -10.25% -38.71%
Return on Assets (ROA)		 -9.99% -4.93% -4.88% -4.20% -5.02% -6.19% -17.61% -0.65% -6.41% -11.13% -40.17%
Return on Common Equity (ROCE)		 -30.61% -16.04% -8.08% -6.01% -8.75% -8.87% -14.66% 0.29% -8.59% -18.23% -71.64%
Return on Equity Simple (ROE_SIMPLE)		 -4.81% -3.93% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -2.46 -1.37 -1.77 -1.29 -1.95 -1.47 -1.36 0.20 -1.29 -2.81 -9.22
NOPAT Margin		 -9.76% -5.44% -5.99% -3.88% -5.71% -5.11% -4.02% 0.53% -3.72% -7.92% -26.73%
Net Nonoperating Expense Percent (NNEP)		 -16.91% -13.63% -6.19% -47.97% -27.15% -52.84% -1,387.49% 12.30% 15.51% 30.32% 88.82%
Return On Investment Capital (ROIC_SIMPLE)		 -2.59% -1.46% -1.86% -1.36% -2.09% -1.68% -1.72% 0.25% -1.58% -3.43% -13.43%
Cost of Revenue to Revenue		 98.46% 92.35% 95.19% 93.19% 95.10% 93.65% 89.56% 88.35% 92.84% 98.92% 95.00%
SG&A Expenses to Revenue		 15.48% 15.41% 13.37% 12.35% 13.06% 13.65% 12.04% 10.90% 12.47% 12.39% 12.89%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 15.48% 15.41% 13.37% 12.35% 13.06% 13.65% 16.18% 10.90% 12.47% 12.39% 43.18%
Earnings before Interest and Taxes (EBIT)		 -3.77 -1.99 -2.72 -2.27 -2.63 -2.45 -2.65 -0.00 -2.11 -3.97 -13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -2.58 -0.89 -1.51 -1.14 -1.50 -1.31 -1.49 1.16 -0.94 -2.78 -12
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.47 0.44 0.24 0.44 0.34 0.28 0.30 0.26 0.33 0.26 0.30
Price to Tangible Book Value (P/TBV)		 0.47 0.44 0.24 0.44 0.34 0.28 0.30 0.26 0.33 0.26 0.30
Price to Revenue (P/Rev)		 0.31 0.31 0.17 0.31 0.22 0.17 0.16 0.13 0.16 0.11 0.11
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.42 0.42 0.25 0.47 0.38 0.28 0.28 0.29 0.42 0.35 0.43
Enterprise Value to Revenue (EV/Rev)		 0.25 0.28 0.18 0.35 0.26 0.17 0.14 0.16 0.24 0.18 0.18
Enterprise Value to EBITDA (EV/EBITDA)		 141.46 33.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 4.00 3.90 0.00 0.00 0.00 0.00 3.17 3.96 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 1.83 2.86 11.94 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.11 0.11 0.15 0.18 0.18 0.14 0.16 0.16 0.22 0.30 0.37
Long-Term Debt to Equity		 0.11 0.11 0.11 0.11 0.11 0.11 0.13 0.12 0.13 0.13 0.20
Financial Leverage		 -0.08 -0.04 -0.02 -0.02 -0.01 -0.02 -0.01 0.05 0.11 0.07 0.08
Leverage Ratio		 1.82 1.82 1.73 1.90 1.89 1.92 2.08 2.13 2.12 2.22 2.35
Compound Leverage Factor		 1.85 1.80 1.77 2.02 2.07 2.07 2.21 141.47 2.34 2.37 2.43
Debt to Total Capital		 9.88% 9.96% 13.26% 15.36% 15.11% 12.56% 13.67% 14.08% 17.87% 22.86% 27.22%
Short-Term Debt to Total Capital		 0.31% 0.31% 3.88% 6.01% 5.69% 2.63% 2.78% 3.43% 7.49% 12.60% 12.36%
Long-Term Debt to Total Capital		 9.57% 9.64% 9.38% 9.35% 9.42% 9.93% 10.89% 10.64% 10.38% 10.26% 14.87%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 90.12% 90.04% 86.74% 84.64% 84.89% 87.44% 86.33% 85.92% 82.14% 77.14% 72.78%
Debt to EBITDA		 40.74 9.19 -2.73 -2.38 -2.80 -2.02 -1.99 -3.61 -5.67 -4.63 -1.30
Net Debt to EBITDA		 -31.41 -3.07 -0.14 -0.72 -1.08 -0.07 0.27 -1.14 -4.21 -2.35 -0.78
Long-Term Debt to EBITDA		 39.47 8.90 -1.93 -1.45 -1.74 -1.60 -1.59 -2.73 -3.29 -2.08 -0.71
Debt to NOPAT		 -3.97 -4.69 -2.11 -2.12 -2.21 -1.70 -1.79 -2.47 -3.72 -3.55 -1.42
Net Debt to NOPAT		 3.06 1.57 -0.11 -0.64 -0.85 -0.06 0.25 -0.78 -2.76 -1.81 -0.85
Long-Term Debt to NOPAT		 -3.85 -4.54 -1.50 -1.29 -1.38 -1.35 -1.42 -1.87 -2.16 -1.59 -0.78
Altman Z-Score		 2.08 2.07 1.71 1.82 1.83 1.80 1.73 1.74 1.73 1.60 1.60
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 4.06 3.98 2.63 2.56 2.70 2.51 2.06 1.92 1.87 1.64 1.73
Quick Ratio		 2.02 1.73 1.23 1.14 1.18 0.95 0.94 0.79 0.66 0.76 0.74
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -81 -82 -0.33 -4.36 -8.28 2.51 15 12 5.39 1.59 -3.46
Operating Cash Flow to CapEx		 81.12% -1,313.04% -262.77% -1,143.85% 3.50% 747.26% 229.90% -390.58% -677.73% 227.55% -167.35%
Free Cash Flow to Firm to Interest Expense		 -1,152.72 -1,112.96 -2.63 -24.50 -29.77 10.20 70.18 53.97 24.07 5.88 -7.43
Operating Cash Flow to Interest Expense		 4.97 -48.97 -21.91 -19.34 0.13 24.36 15.70 -17.80 -28.26 9.27 -2.29
Operating Cash Flow Less CapEx to Interest Expense		 -1.16 -52.70 -30.25 -21.03 -3.67 21.10 8.87 -22.36 -32.43 5.20 -3.65
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.82 0.78 0.77 0.70 0.78 0.81 0.83 0.85 0.87 0.92 1.02
Accounts Receivable Turnover		 12.22 10.71 9.52 8.25 8.91 10.97 8.24 7.36 7.80 8.80 8.08
Inventory Turnover		 6.00 5.20 3.96 4.35 5.38 4.92 4.91 4.35 4.35 4.60 4.80
Fixed Asset Turnover		 2.40 2.29 2.15 2.15 2.34 2.44 2.52 2.64 2.65 2.80 3.30
Accounts Payable Turnover		 15.70 15.72 10.42 12.19 14.24 11.96 8.58 8.19 9.78 8.46 7.97
Days Sales Outstanding (DSO)		 29.87 34.07 38.35 44.22 40.97 33.26 44.32 49.60 46.80 41.47 45.20
Days Inventory Outstanding (DIO)		 60.79 70.20 92.07 83.98 67.90 74.14 74.35 83.94 83.85 79.26 76.03
Days Payable Outstanding (DPO)		 23.25 23.22 35.02 29.95 25.63 30.53 42.52 44.57 37.33 43.13 45.79
Cash Conversion Cycle (CCC)		 67.41 81.05 95.40 98.24 83.24 76.87 76.15 88.97 93.32 77.60 75.44
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 78 81 83 85 85 77 67 73 78 73 61
Invested Capital Turnover		 3.27 2.97 1.36 1.36 1.50 1.59 1.73 1.71 1.66 1.90 2.22
Increase / (Decrease) in Invested Capital		 78 81 -1.44 3.08 6.33 -3.98 -16 -12 -6.68 -4.40 -5.76
Enterprise Value (EV)		 33 34 20 40 32 22 19 21 33 26 26
Market Capitalization		 40 37 20 36 27 21 20 18 22 16 15
Book Value per Share		 $14.03 $13.81 $25.18 $12.94 $12.77 $12.36 $11.07 $11.17 $10.85 $10.22 $7.96
Tangible Book Value per Share		 $14.03 $13.81 $25.18 $12.94 $12.77 $12.36 $11.07 $11.17 $10.85 $10.22 $7.96
Total Capital		 95 93 95 95 93 88 79 80 82 82 69
Total Debt		 9.37 9.30 13 15 14 11 11 11 15 19 19
Total Long-Term Debt		 9.08 9.01 8.93 8.86 8.78 8.70 8.63 8.55 8.47 8.39 10
Net Debt		 -7.22 -3.11 0.65 4.40 5.42 0.40 -1.49 3.57 11 9.51 11
Capital Expenditures (CapEx)		 0.43 0.28 1.03 0.30 1.06 0.80 1.46 1.03 0.93 1.10 0.64
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 25 29 30 34 34 27 20 26 31 26 29
Debt-free Net Working Capital (DFNWC)		 41 41 42 44 42 38 33 34 35 35 36
Net Working Capital (NWC)		 41 41 38 38 37 35 30 31 29 25 28
Net Nonoperating Expense (NNE)		 0.61 0.21 0.11 0.70 0.25 0.72 5.86 0.49 1.26 1.50 4.32
Net Nonoperating Obligations (NNO)		 -7.22 -3.11 0.65 4.40 5.42 0.40 -1.49 3.57 11 9.51 11
Total Depreciation and Amortization (D&A)		 1.19 1.10 1.21 1.13 1.13 1.14 1.16 1.17 1.17 1.19 1.18
Debt-free, Cash-free Net Working Capital to Revenue		 19.32% 23.79% 26.24% 29.73% 27.52% 21.44% 15.67% 19.46% 22.96% 18.32% 20.16%
Debt-free Net Working Capital to Revenue		 32.30% 34.12% 36.77% 38.72% 34.63% 29.89% 25.16% 25.22% 25.73% 24.80% 25.40%
Net Working Capital to Revenue		 32.08% 33.87% 33.52% 33.68% 30.28% 28.06% 23.47% 23.17% 21.21% 17.53% 19.45%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.52) ($0.27) ($0.32) $0.00 ($0.37) ($0.37) ($1.21) ($0.05) ($0.42) ($0.72) ($2.24)
Adjusted Weighted Average Basic Shares Outstanding		 5.85M 5.87M 5.87M 0.00 5.92M 5.94M 5.95M 6.01M 6.01M 6.03M 6.03M
Adjusted Diluted Earnings per Share		 ($0.52) ($0.27) ($0.32) $0.00 ($0.37) ($0.37) ($1.21) ($0.05) ($0.42) ($0.72) ($2.24)
Adjusted Weighted Average Diluted Shares Outstanding		 5.85M 5.87M 5.87M 0.00 5.92M 5.94M 5.95M 6.01M 6.01M 6.03M 6.03M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 6.09M 3.28M 6.20M 0.00 6.20M 6.18M 6.18M 6.18M 6.18M 6.28M 22.11M
Normalized Net Operating Profit after Tax (NOPAT)		 -2.46 -1.37 -1.77 -1.29 -1.95 -1.47 -1.36 0.20 -1.29 -2.81 -9.22
Normalized NOPAT Margin		 -9.76% -5.44% -5.99% -3.88% -5.71% -5.11% -4.02% 0.53% -3.72% -7.92% -26.73%
Pre Tax Income Margin		 -15.20% -7.83% -9.43% -7.28% -8.41% -9.18% -8.32% -0.53% -6.69% -11.96% -39.10%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -53.91 -26.88 -21.90 -12.74 -9.46 -9.95 -12.44 -0.01 -9.40 -14.71 -28.00
NOPAT to Interest Expense		 -35.13 -18.46 -14.25 -7.22 -7.00 -5.98 -6.39 0.88 -5.77 -10.41 -19.79
EBIT Less CapEx to Interest Expense		 -60.04 -30.61 -30.24 -14.43 -13.26 -13.21 -19.27 -4.57 -13.57 -18.79 -29.37
NOPAT Less CapEx to Interest Expense		 -41.26 -22.19 -22.59 -8.91 -10.80 -9.24 -13.22 -3.68 -9.94 -14.48 -21.16
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -10.81% -6.56% -3.06% -2.69% -3.00% -2.19% -1.31% -1.47% -1.43% -0.62% -0.43%

Financials Breakdown Chart

Key Financial Trends

Natural Alternatives International (NASDAQ:NAII) shows improving revenue scale but continued profitability and cash-flow pressure. Based on the supplied quarterly statements, revenue has generally grown from 2024 levels, but gross margins remain thin and the company has reported recurring net losses. The latest quarter was particularly weak, with a sharp increase in the net loss and negative operating cash flow.

  • Revenue is higher than a year ago. Quarterly revenue increased from $29.5 million in Q4 2024 to $33.9 million in Q4 2025 and $34.5 million in Q4 2026. Revenue also rose year over year in Q3 2026, reaching $35.5 million versus $28.8 million in Q3 2025.
  • Operating cash flow briefly improved. NAII generated $2.5 million of operating cash flow in Q3 2026 after using $4.0 million in Q1 and $6.3 million in Q2. This improvement was supported by noncash adjustments and working-capital changes, although it did not continue into Q4.
  • Liquidity improved from the end of 2025. Cash and equivalents increased from $3.8 million at December 31, 2025, to $9.2 million at March 31, 2026. Even after the $1.7 million decline in cash during Q4 2026, the company’s implied cash balance remained above the December level.
  • The company continues to invest in property and equipment. Capital expenditures totaled approximately $3.7 million across the first four quarters of fiscal 2026, indicating continued investment in operating capacity despite the current losses.
  • Debt financing has helped manage liquidity but has not materially reduced leverage. In Q4 2026, NAII issued $69.6 million of debt and repaid $69.6 million, producing a nearly flat financing cash-flow result. This appears primarily to reflect refinancing activity rather than meaningful debt reduction.
  • Share repurchases have been minimal. Repurchases were generally small, including $2,000 in Q4 2026 and $82,000 in Q3 2026. The modest decline in weighted-average shares over the broader period may provide limited per-share support, but buybacks are not a significant capital-allocation factor currently.
  • Profitability has deteriorated sharply. NAII reported a net loss of $13.5 million, or $2.24 per diluted share, in Q4 2026. This compares with losses of $4.3 million in Q3 and $2.6 million in Q2, and represents a significant setback from the $291,000 loss in Q1.
  • Gross margins remain insufficient to cover operating expenses. Gross profit fell from $4.4 million in Q1 2026 to only $383,000 in Q3 before recovering to $1.7 million in Q4. The Q4 gross margin was approximately 5%, well below the roughly 13% margin recorded in Q1, while operating expenses remained elevated at $14.9 million.
  • Operating cash flow turned negative again. The company used $1.1 million of cash in operating activities during Q4 2026 after generating $2.5 million in Q3. Across the first four quarters of fiscal 2026, operating cash flow was approximately negative $4.9 million, increasing reliance on financing and existing liquidity.
  • The balance sheet remains exposed to working-capital and liability risks. Inventory stood at $29.9 million and accounts receivable at $20.6 million at March 31, 2026, tying up substantial capital. Total liabilities of $91.8 million exceeded 1.4 times shareholders’ equity, while total equity declined from $84.1 million in March 2024 to $63.1 million in March 2026.

For investors, the main potential positive is revenue growth and the possibility that recent investments could eventually improve operating efficiency. However, NAII must restore gross margins, return to consistently positive operating cash flow and contain its recurring losses before the financial trend can be considered durable. The supplied data also includes several restated and calculated statements, so investors should confirm the latest figures against the company’s filed annual report and subsequent balance sheet.

10/09/26 12:37 PM ETAI Generated. May Contain Errors.

Natural Alternatives International Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Natural Alternatives International's fiscal year ends in June. Their fiscal year 2026 ended on June 30, 2026.

Natural Alternatives International's net income appears to be on a downward trend, with a most recent value of -$20.70 million in 2026, compared with $9.55 million in 2016. The previous period was -$13.58 million in 2025. Check out Natural Alternatives International's forecast to explore projected trends and price targets.

Natural Alternatives International's total operating income in 2026 was -$18.75 million, based on the following breakdown:
  • Total Gross Profit: $9.00 million
  • Total Operating Expenses: $27.75 million

Over the last 10 years, Natural Alternatives International's total revenue changed from $114.20 million in 2016 to $142.52 million in 2026, a change of 24.8%.

In the past 10 quarters, Natural Alternatives International's cash and equivalents has ranged from $3.75 million in Q2 2026 to $16.75 million in Q1 2024, and is currently $9.20 million as of their latest financial filing in Q3 2026.

Natural Alternatives International had total debt of $18.69 million at the end of 2026, a 72.5% increase from 2025, and none in 2016.

Over the last 10 years, Natural Alternatives International's book value per share changed from 7.82 in 2016 to 7.96 in 2026, a change of 1.8%.


Related Companies

Financial statements for NASDAQ:NAII last updated on 9/28/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel